Aihong Huo

Title: Aihong Huo: Innovator in Oncology

Introduction

Aihong Huo is a prominent inventor based in Tianjin, China. She has made significant contributions to the field of oncology through her innovative research and development of pharmaceutical compounds. With a total of 2 patents, her work focuses on advancing cancer treatment options.

Latest Patents

Aihong Huo's latest patents include the development of tetracyclic anthraquinone derivatives. These patents disclose a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The invention outlines a method for treating cancer by administering a therapeutically effective amount of the compound to a subject in need. The compounds possess good anticancer and/or antitumor activity, along with excellent water solubility and stability, ensuring good tolerance in animal bodies. Additionally, the patents describe a process for preparing the compound represented by formula (I).

Career Highlights

Throughout her career, Aihong Huo has worked with notable companies such as Tianjin Hemay Oncology Pharmaceutical Co., Ltd. and Tianjin Hemay Bio-tech Co., Ltd. Her experience in these organizations has allowed her to contribute significantly to the development of innovative cancer therapies.

Collaborations

Aihong Huo has collaborated with esteemed colleagues, including Hesheng Zhang and Zhenzhong Li. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.

Conclusion

Aihong Huo's contributions to oncology through her patents and collaborations highlight her dedication to improving cancer treatment options. Her innovative work continues to pave the way for advancements in the pharmaceutical industry.